Literature DB >> 9465301

Genomic organization of the UBE3A/E6-AP gene and related pseudogenes.

T Kishino1, J Wagstaff.   

Abstract

The UBE3A gene encodes the E6-AP ubiquitin-protein ligase and has recently been shown to be mutated in Angelman syndrome patients who lack 15q11-q13 deletions or chromosome 15 paternal uniparental disomy. Previous UBE3A cDNA analysis has shown a coding region of approximately 2.6 kb and a 3'-untranslated region (UTR) of < 50 bp, whereas Northern analysis has indicated mRNA sizes of 5-8 kb. We have analyzed additional cDNA clones and provide evidence for an additional 0.5 kb of 5'-UTR and > 2 kb of 3'-UTR. We have established the genomic organization of UBE3A and the sequence of intron-exon borders. We have also mapped two highly homologous processed pseudogenes, UBE3AP1 and UBE3AP2, to chromosomes 2 and 21, respectively, and determined their genomic organization. These results will form the basis for studies of mutation and imprinting of UBE3A.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9465301     DOI: 10.1006/geno.1997.5093

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Novel deletion of the E3A ubiquitin protein ligase gene detected by multiplex ligation-dependent probe amplification in a patient with Angelman syndrome.

Authors:  Francesco Cali; Alda Ragalmuto; Valeria Chiavetta; Giuseppe Calabrese; Marco Fichera; Mirella Vinci; Giuseppa Ruggeri; Pietro Schinocca; Maurizio Sturnio; Salvatore Romano; Valentino Romano; Maurizio Elia
Journal:  Exp Mol Med       Date:  2010-12-31       Impact factor: 8.718

2.  Mutation analysis of UBE3A in Angelman syndrome patients.

Authors:  P Malzac; H Webber; A Moncla; J M Graham; M Kukolich; C Williams; R A Pagon; L A Ramsdell; T Kishino; J Wagstaff
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

3.  The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase.

Authors:  Melissa L Kelley; Kerri E Keiger; Chan Jae Lee; Jon M Huibregtse
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Molecular and Clinical Aspects of Angelman Syndrome.

Authors:  A Dagli; K Buiting; C A Williams
Journal:  Mol Syndromol       Date:  2011-07-28

5.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

Review 6.  Epilepsy in Prader-Willi syndrome: clinical, diagnostic and treatment aspects.

Authors:  Alberto Verrotti; Claudia Soldani; Daniela Laino; Renato d'Alonzo; Salvatore Grosso
Journal:  World J Pediatr       Date:  2014-05-07       Impact factor: 2.764

7.  Imprinted expression of UBE3A in non-neuronal cells from a Prader-Willi syndrome patient with an atypical deletion.

Authors:  Kristen Martins-Taylor; Jack S Hsiao; Pin-Fang Chen; Heather Glatt-Deeley; Adam J De Smith; Alexandra I F Blakemore; Marc Lalande; Stormy J Chamberlain
Journal:  Hum Mol Genet       Date:  2013-12-20       Impact factor: 6.150

Review 8.  Angelman syndrome - insights into a rare neurogenetic disorder.

Authors:  Karin Buiting; Charles Williams; Bernhard Horsthemke
Journal:  Nat Rev Neurol       Date:  2016-09-12       Impact factor: 42.937

9.  Serological detection of cutaneous T-cell lymphoma-associated antigens.

Authors:  S Eichmuller; D Usener; R Dummer; A Stein; D Thiel; D Schadendorf
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-09       Impact factor: 11.205

10.  Imprinting analysis by droplet digital PCR coupled with locked nucleic acid TaqMan probes.

Authors:  Maiko Mitake; Shiori Hirano; Tatsuya Kishino
Journal:  Epigenetics       Date:  2020-09-24       Impact factor: 4.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.